Point: Major adverse cardiovascular events and anti-IL 12/23 agents

J Am Acad Dermatol. 2014 Feb;70(2):380-1. doi: 10.1016/j.jaad.2013.07.050.

¹ Department of Pharmacology and Clinical Pharmacology, Aristotle University of Thessaloniki, Thessaloniki, Greece; Departments of Dermatology, Venereology, Allergology and Immunology, Dessau Medical Center, Dessau, Germany.
² Hospital for Skin and Venereal Diseases, Thessaloniki, Greece.
³ Departments of Dermatology, Venereology, Allergology and Immunology, Dessau Medical Center, Dessau, Germany. Electronic address: christos.zouboulis@klinikum-dessau.de.

No abstract available

Publication types